Sun Pharmaceutical Industries Limited has informed the Exchange about Receipt of requests for reclassification of shareholder category
SUNPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.0 pts more than Nifty 100 and 1.8 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Three members of the Sun Pharma Promoter Group — Mr. Sudhir Vrundavandas Valia, Mrs. Raksha Sudhir Valia, and Mrs. Krishna Vrundavandas Valia — have requested reclassification from the 'Promoter Group' to the 'Public' category under SEBI Listing Regulations. The three together hold 4,31,75,371 shares representing 1.80% of the company's share capital. The requests were received on 14 May 2026 and will be examined by the company and placed before the Board of Directors. The reclassification is subject to prescribed regulatory process and stock exchange approval. This is a disclosure of intent rather than a completed transaction.
If approved, the reclassification would reduce the official Promoter Group holding by 1.80%. This could signal potential future stake disposal by these shareholders and may have a mild negative sentiment as it indicates exits from the promoter group, though the percentage is relatively small.